Racial Variation in the Complexity of Coronary Artery Disease in Patients with Acute ST-Segment Elevation Myocardial

Ayman Elbadawi1, Erfan Alotaki2, Carlos Vazquez3

  • 1Division of Cardiovascular Medicine, University of Texas Medical Branch, Galveston, TX, United States of America.

Insights

This study found no racial differences in coronary artery disease complexity among ST-elevation myocardial infarction (STEMI) patients receiving percutaneous coronary intervention. Chronic kidney disease, not race, predicted higher disease complexity in STEMI patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Disparities

Background:

  • Racial variations in the presentation of ST-segment elevation myocardial infarction (STEMI) have been suggested.
  • Understanding these variations is crucial for equitable patient care.

Purpose of the Study:

  • To investigate racial variations in the complexity of coronary artery disease (CAD) among patients with STEMI.
  • To identify predictors of higher CAD complexity in this patient population.

Main Methods:

  • Retrospective analysis of STEMI patients who underwent primary percutaneous coronary intervention (PCI) at a tertiary center (2012-2016).
  • Coronary artery disease complexity was assessed using the SYNTAX score.
  • Logistic regression analysis was employed to identify predictors of higher SYNTAX scores.

Main Results:

  • The study included 260 patients: 201 Whites, 24 African Americans, 19 Hispanics, and 15 of other ethnicities.
  • No significant differences in SYNTAX scores were observed across racial groups (p=0.965).
  • Chronic kidney disease was identified as the sole significant predictor of higher SYNTAX scores (p=0.026).

Conclusions:

  • This study did not find evidence of racial variations in coronary artery disease complexity for STEMI patients.
  • Larger-scale studies are warranted to further explore potential racial disparities in STEMI patient populations.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
443
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
372
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
687
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
990